Community pharmacist–led telephone follow-up enabled close management of everolimus-induced adverse events in an outpatient with metastatic breast cancer
-
- Satoshi Yokoyama
- Laboratory of Community Pharmacy (Yokoyama, Yajima, Sakai, Ino, Iguchi), Gifu Pharmaceutical University, Gifu, Japan
-
- Satoko Yajima
- Laboratory of Community Pharmacy (Yokoyama, Yajima, Sakai, Ino, Iguchi), Gifu Pharmaceutical University, Gifu, Japan
-
- Chihiro Sakai
- Laboratory of Community Pharmacy (Yokoyama, Yajima, Sakai, Ino, Iguchi), Gifu Pharmaceutical University, Gifu, Japan
-
- Shuji Yamashita
- Laboratory of Community Pharmacy (Yokoyama, Yajima, Sakai, Ino, Iguchi), Gifu Pharmaceutical University, Gifu, Japan
-
- Yoshihiro Noguchi
- Laboratory of Community Pharmacy (Yokoyama, Yajima, Sakai, Ino, Iguchi), Gifu Pharmaceutical University, Gifu, Japan
-
- Yoko Ino
- Laboratory of Community Pharmacy (Yokoyama, Yajima, Sakai, Ino, Iguchi), Gifu Pharmaceutical University, Gifu, Japan
-
- Kazuhiro Iguchi
- Laboratory of Community Pharmacy (Yokoyama, Yajima, Sakai, Ino, Iguchi), Gifu Pharmaceutical University, Gifu, Japan
-
- Hitomi Teramachi
- Laboratory of Community Pharmacy (Yokoyama, Yajima, Sakai, Ino, Iguchi), Gifu Pharmaceutical University, Gifu, Japan
収録刊行物
-
- Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
-
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada 150 (6), 362-365, 2017-09-22
SAGE Publications